A phase Ia/Ib trial of the DNA-dependent protein kinase inhibitor (DNA-PKi) M3814 in combination with radiotherapy in patients with advanced solid tumors

Authors
Category Primary study
JournalJournal of clinical oncology
Year 2017
This article has no abstract
Epistemonikos ID: fbe189148e6b42e8449ee27cf0005675b27fd4f8
First added on: Feb 08, 2025